Introduction
Adolescence is a time of significant physical, behavioural, and psychological change [
1]. Emotional, social, and mental well-being predict age-appropriate developmental trajectories, future risk for psychological impairment, and long-term health [
2,
3]. In about half of mental disorders, symptoms appear well before the age of 18 [
4]. For adolescents suffering from chronic disease, the common changes they experience during adolescence are compounded by the challenge of figuring out how to manage a chronic disease independently and how best to make the transition from paediatric to adult care [
5]. In addition, young patients who suffer from chronic diseases show a less favourable course of mental symptoms over time [
6].
Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in paediatrics describing a heterogeneous group of inflammatory rheumatic diseases of unknown origin. It begins before the age of 16, persists for at least 6 weeks and is diagnosed after exclusion of any other known arthritis causes [
7]. Affected individuals experience joint pain and swelling, morning stiffness, and limited mobility. Long-term consequences of JIA include joint damage, muscle weakness and atrophy, growth disturbances, and comorbid conditions like uveitis might develop during the disease course [
8]. Resulting restrictions in daily life, time-consuming physical therapies, and medication side effects can fuel dissatisfaction and psychological distress, which in turn detoriates disease self-management and treatment adherence [
9,
10].
While previous studies have shown that growing up with rheumatic conditions can be associated with poorer psychological functioning [
11], studies on depression and anxiety in paediatric patients with JIA and the possible association of these symptoms with disease characteristics are limited and provide conflicting results [
9,
12‐
18]. In fact, studies on mental health in JIA reported rates of depressive and anxious symptoms ranging from 7 to 36% and 7–64%, respectively, and were often limited by small sample sizes. As anxiety and depressive symptoms may be non-specific, unreported, or even concealed by patients, targeted screening methods can be used to identify mental health problems [
19]. Although international professional societies and task forces advocate the routine use of psychosocial screening tools during adolescence [
20‐
23], it has not yet been implemented in most paediatric rheumatology centres. This situation hinders early and effective provision of mental health services and might in turn impair the outcome of the underlying disease.
In this study we analysed the prevalence of anxious and depressive symptoms captured by a standardized outpatient screening in adolescents and young adults (AYA) with JIA in Germany and assessed the association of sociodemographic, clinical parameters, and patient reported outcomes of JIA with symptoms of anxiety and depression.
Discussion
Based on one of the most extensive screening analyses of internalizing symptoms conducted in paediatric JIA patients to date, we found a high prevalence of primary mild depressive or anxious symptoms. While the frequency of anxious symptoms was similar to that of depressive symptoms, more than one in ten patients reported signs of suicidal or self-harm thoughts.
Few previous studies on internalizing symptoms in JIA have highlighted an increased risk in specific outcomes such as depression and anxiety compared to the general population [
9,
39‐
41]. Methodological discrepancies, but also sometimes small heterogeneous samples, differences in disease durations/activities, and the high rate of mental health problems in the general population may explain why some previous studies have stated no increased risk of mental health problems in JIA patients compared to general population controls [
13,
15‐
18,
43]. As our study did not include a control group, an exact comparison with the general population is not possible. However, the prevalence of anxiety symptoms found in our study seems to be slightly higher than German normative data [
44] and also slightly higher than the prevalence recently reported among adolescents from the general population [
45]. A previous study from the German general population on prevalence and severity of depressive symptoms showed results comparable to those found in our patients from the same age group [
46]. Another study conducted among adolescents from the German general population, however, reported a higher mean PHQ-9 score compared to our findings [
47]. In these studies, and also in ours, screening took place immediately before and/or during the Corona pandemic, a period in which the school-aged population was exposed to increased psychological stress [
48]. However, potential negative effects were neither reflected in the severity of depressive symptoms (PHQ-9) in an adolescent sample from the German general population [
47] nor in the frequency of psychological diagnoses in adolescents with JIA [
49], at least until 2021.
In our study, a high proportion of patients showed signs of suicidal or self-harm thoughts, which were based on the final item of PHQ-9. Although it is widely used as a single scale for studies on the prevalence of suicidal ideas, however, the predictive value of PHQ-9 item 9 on suicide risk remains unclear and the combination with self-harm in one item can be misleading [
50]. Alternatively, one could add a more in-depth evidence-based self-report for the assessment of suicidal ideas and suicidality in case of PHQ-9 item 9 > score 0. This might improve acceptance of such an assessment amongst clinicians. Moreover, research highlights the fact, that PHQ-9 item-9 might not only result in a very high false-positive rate, but also lack specificity, strengthening the call for a more reliable and valid procedure that yet need to be further detailed and examined [
51]. Defined clinical pathways to implement screening programs might thereby aid with an efficient detecting and managing of patients who are at risk for suicide [
52]. National and international organizations have issued guidelines for the prevention of suicide in young people including comprehensive diagnostics [
53].
Consistent with trends in the general population [
42] and those previously reported in JIA [
14,
18,
41,
54], our results showed that females were more likely to have conspicuous screening results and higher symptom severity than males. Moreover, we have shown that the risk for conspicuous depressive and anxiety symptoms increases significantly with age, with older patients more frequently reporting higher symptom severity. Thus, our results confirm previous studies on the association between age and mental health in JIA [
14,
17,
19]. As clinically significant symptoms occurred most frequently in early adulthood, it probably negatively affects the already challenging transition process to internal medicine rheumatology.
A previous work by Kyllönen et al. [
54] focused on the impact of the age at JIA onset on behavioural disorders and summarized that this may have implications for future mental health. In our study, we found no association between age at JIA onset and internalizing symptoms, however, due to our cross-sectional study design, comparison with this previous study remains difficult.
Our results do not confirm previous findings by El-Najjar et al. [
55], demonstrating that longer disease duration is associated with higher risk of depressive symptoms. Instead, the comparatively long disease duration of our patients of more than 7 years supports the theory that longer disease duration allows some adolescents to adapt and improve. This assumption corresponds with the hypothesis of Butler et al. [
56], who assumed that symptoms would improve after initial adjustment to disease, and found a slight decrease in symptoms at six-month follow-up. This is also supported by an earlier study showing that adolescents with lower anxiety and depressive symptoms tended to have a longer disease duration [
57].
Our results support previous findings, showing that patients with a polyarticular course are at higher risk for depression than patients from other categories [
9,
14]. In contrast, El-Najjar et al. [
55] and Fair et al. [
17] did not find a statistically significant difference in symptom severity between various JIA categories. This discrepancy might be attributed to small sample sizes for some categories.
Our findings are consistent with a number of previous studies reporting associations between markers of disease activity and internalizing symptoms such as depression and anxiety [
13,
15,
55,
58]. However, Ding et al. [
16] and Fair et al. [
17] did not find any association between disease activity and psychological functioning, which may be due to the fact that most of patients studied had either inactive or low disease activity. Similar to Tarakci et al. [
13] and Roemer et al. [
58], but in contrast to few previous studies [
14,
55] we did not find an association between the number of active joints and conspicuous screening results. Hanns et al. [
14] noted that a higher active joint count correlated with higher depressive scores in the first year, but this relationship was no longer significant after follow up four years later. A possible explanation for the conflicting baseline result reported by Hanns et al. [
14] is the comparatively very low number of active joints in our study sample.
It should be noted that all of these previous studies have used different assessment tools and are from mixed populations of children and adolescents, both of which may be factors contributing to differences in findings.
Another important aspect is that due to the cross-sectional nature of our and most previous studies, the directionality of the associations remains unknown. However, it seems plausible that depressive symptoms may lead to worsening disease activity, especially when patients do not adhere to medical care because of their psychological symptoms. In other disease processes, including childhood lupus, depressive symptoms have already been associated with poor treatment adherence [
10], highlighting the importance of mental health screening.
We observed that patients receiving conventional synthetic DMARD therapy were more likely to experience moderate to severe depressive symptoms than those without such therapy. One explanation might include known side effects such as nausea and vomiting, particularly caused by methotrexate [
59], which can negatively affect mood and quality of life.
According to results of our study, patients with conspicuous screening results rated their physical functioning as measured by CHAQ significantly worse than those with inconspicuous screening results. Furthermore, a higher CHAQ sum score significantly increased the likelihood of a conspicuous screening result in multivariable analyses. These results are thus in line with a number of previous studies [
9,
13,
14,
16,
17,
55]. Moreover, Hanns et al. [
14] even showed that a higher baseline depressive score predicted greater functional impairment and pain 1 to 4 years later.
As in most previous studies [
14,
17,
55,
57,
58], patients with more severe pain were more likely to report symptoms of depression and anxiety. It is well known that pain is a risk factor for the development of mental disorders, especially in other painful conditions such as fibromyalgia [
60]. Intervention studies focusing on coping strategies for pain may help improve mental health outcomes in the future. Similar to that observed for pain, patients with conspicuous screening result reported significantly worse coping with their rheumatic disease, more severe fatigue, and poorer patient-reported global assessment of current health compared to those with inconspicuous screening result. Some patient-reported outcomes were associated with depressive or anxious symptoms independently of objective parameters such as the number of active joints, suggesting that psychological comorbidity may develop independently of somatic disease activity. Consequently, the risk for depression and anxiety should not be derived only from the objectifiable burden of disease, which again highlights the need for regular, no-cause screening for depressive and anxiety symptoms in JIA.
This is the first study examining and demonstrating a significant association between participation in sports and mental health outcomes in adolescents with JIA. This was already shown in an earlier study among healthy adolescents [
61]. However, data on the impact of regular exercise on mental health in adolescents with JIA are still lacking and should be part of future research.
Strength and limitations
The strengths of our study include a multicentre outpatient screening based on one of the most extensive JIA cohorts to date. With the integration of screening into an existing large patient register and a JIA category distribution that differs only slightly from that previously reported for Europe [
62], we can assume a representative sample. This study provides new insights on prevalence and severity of depression and anxiety symptoms, taking into account sociodemographic, clinical, and personal factors, as well as general and disease-specific tools.
Nevertheless, our results must be interpreted in light of several limitations. Due to the cross-sectional nature of this study, courses of mental health issues could not be analysed and causation cannot be assessed. In order to detect symptoms of anxiety and depression at an early stage, we chose a cut-off value of 7 in the present study. GAD-7 and PHQ-9 are sensitive, self-administered screening instruments for mental disorders that are typically used in outpatient and primary care settings for referral to mental health specialists. However, they cannot be used as a replacement for clinical assessment, and additional evaluations should be performed to confirm a diagnosis of a mental disorder. At the beginning of our screening phase, no PHQ-9 version validated for individuals aged < 18 existed. We therefore consistently used the version for individuals aged ≥ 18 years.
Although we were able to consider many associations with various variables, we do not have information on all potential risk factors and behaviours, such as family characteristics, socioeconomic status, education level, diet, or other stressful life events. Furthermore, we are not able to provide information about the countries of origin, but assume that they were mainly in Europe. Due to screening within an existing patient register, the results are based exclusively on data from patients receiving paediatric rheumatology care.
As the questionnaire was only offered in German, the migration share among the study participants is probably lower than in the general German population. Although we adjusted for survey date in our analyses, we cannot rule out pandemic-related influences that may have contributed to a temporary effect on individual mental well-being.
Mental health screening among adolescents and young adults with JIA conducted in routine outpatient care indicates a similarly high prevalence of anxiety and depression symptoms as in the general population. However, these young people already have to manage their somatic chronic disease and the psychological comorbidities can impede the management of the chronic disease. Therefore, the need for routine screening to detect mental health problems has become apparent.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.